Biotechnology Application Centre

Loading...

About Biotechnology Application Centre

BAC is an established biotech company providing the life science industry with unparalleled protein purification technologies for drug manufacture and research. BAC has developed unique affinity ligand products for a wide variety of target biotherapeutic compounds, ranging from antibodies and antibody fragments, recombinant and plasma proteins to even viral particles. CaptureSelect ligands can be developed for almost any purification challenge, and offer numerous advantages such as an increase in overall yield, reduction of process steps and increase in product purity all resulting in lower cost of goods. Next to that, CaptureSelect ligands can be tailored to protect the biopharmaceutical using mild elution conditions. A number of CaptureSelect products are currently in use for production of clinical trial material.

Facts about Biotechnology Application Centre
  • Focus : Manufacturer
  • Industry : Biotechnology

Product portfolio of Biotechnology Application Centre

News about Biotechnology Application Centre

Here you will find BAC B.V.

See the theme worlds for related content

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

View topic world

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous